Primelink Biotherapeitics(shenzhen) Limited
Clinical trials sponsored by Primelink Biotherapeitics(shenzhen) Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug PLB-002 targets Hard-to-Treat cancers in early trial Results expected Jun 2027 (estimated)